Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

The practice of “liquid biopsy” as a diagnostic, prognostic and theranostic tool in non-small cell lung cancer (NSCLC) patients is an appealing approach, at least in theory, since it is noninvasive and easily repeated. In particular, this approach allows patient monitoring during treatment, as well...

Full description

Saved in:
Bibliographic Details
Published in:Ann Transl Med
Main Authors: Ilie, Marius, Hofman, Véronique, Long, Elodie, Bordone, Olivier, Selva, Eric, Washetine, Kevin, Marquette, Charles Hugo, Hofman, Paul
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2014
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4245510/
https://ncbi.nlm.nih.gov/pubmed/25489581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2305-5839.2014.08.11
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items